Cierra N. Sharp

Cierra N. Sharp

Jun 14, 2016

Group 6 Copy 16
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we use fungi to break down our plastic and rubber waste?

    The massive and rapid accumulation of our plastic and rubber waste is a problem that we cannot afford...

    Blinded by the light: reducing shearwater deaths along a coastal highway in O'ahu, Hawai'i

    Wedge-tailed Shearwater chicks are attracted to lights and grounded due to collisions with utility wires / posts...

    Backer Badge Funded